Skip to main content

Advertisement

SpringerLink
Log in

Neural inflammation and the microglial response in diabetic retinopathy

  • Published:
Journal of Ocular Biology, Diseases, and Informatics

Abstract

This chapter reviews the function of microglia and their potential roles in neural inflammation and pathological changes during diabetic retinopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. Physiology of microglia. Physiol Rev. 2011;91:461–553.

    Article  PubMed  CAS  Google Scholar 

  2. Saijo K, Glass CK. Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol. 2011;11:775–87. doi:710.1038/nri3086.

    Article  PubMed  CAS  Google Scholar 

  3. Chan WY, Kohsaka S, Rezaie P. The origin and cell lineage of microglia: new concepts. Brain Res Rev. 2007;53:344–54.

    Article  PubMed  CAS  Google Scholar 

  4. Graeber MB, Li W, Rodriguez ML. Role of microglia in CNS inflammation. FEBS Lett. 2011;30:30.

    Google Scholar 

  5. Krady JK, Basu A, Allen CM, Xu Y, LaNoue KF, Gardner TW, et al. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes. 2005;54:1559–65.

    Article  PubMed  CAS  Google Scholar 

  6. Dheen ST, Kaur C, Ling EA. Microglial activation and its implications in the brain diseases. Curr Med Chem. 2007;14:1189–97.

    Article  PubMed  CAS  Google Scholar 

  7. Rivest S. Regulation of innate immune responses in the brain. Nat Rev Immunol. 2009;9:429–39.

    Article  PubMed  CAS  Google Scholar 

  8. Blach-Olszewska Z, Leszek J. Mechanisms of over-activated innate immune system regulation in autoimmune and neurodegenerative disorders. Neuropsychiatr Dis Treat. 2007;3:365–72.

    PubMed  CAS  Google Scholar 

  9. Glezer I, Simard AR, Rivest S. Neuroprotective role of the innate immune system by microglia. Neuroscience. 2007;147:867–83. Epub 2007 Apr 2024.

    Article  PubMed  CAS  Google Scholar 

  10. Polazzi E, Monti B. Microglia and neuroprotection: from in vitro studies to therapeutic applications. Prog Neurobiol. 2010;92:293–315. Epub 2010 Jul 2014.

    Article  PubMed  Google Scholar 

  11. Simard AR, Rivest S. Neuroprotective effects of resident microglia following acute brain injury. J Comp Neurol. 2007;504:716–29.

    Article  PubMed  CAS  Google Scholar 

  12. Hume DA, Perry VH, Gordon S. Immunohistochemical localization of a macrophage-specific antigen in developing mouse retina: phagocytosis of dying neurons and differentiation of microglial cells to form a regular array in the plexiform layers. J Cell Biol. 1983;97:253–7.

    Article  PubMed  CAS  Google Scholar 

  13. Santos AM, Martin-Oliva D, Ferrer-Martin RM, Tassi M, Calvente R, Sierra A, et al. Microglial response to light-induced photoreceptor degeneration in the mouse retina. J Comp Neurol. 2010;518:477–92.

    Article  PubMed  CAS  Google Scholar 

  14. Lee JE, Liang KJ, Fariss RN, Wong WT. Ex vivo dynamic imaging of retinal microglia using time-lapse confocal microscopy. Invest Ophthalmol Vis Sci. 2008;49:4169–76. Epub 2008 May 4116.

    Article  PubMed  Google Scholar 

  15. Xu H, Chen M, Mayer EJ, Forrester JV, Dick AD. Turnover of resident retinal microglia in the normal adult mouse. Glia. 2007;55:1189–98.

    Article  PubMed  Google Scholar 

  16. Kaneko H, Nishiguchi KM, Nakamura M, Kachi S, Terasaki H. Characteristics of bone marrow-derived microglia in the normal and injured retina. Invest Ophthalmol Vis Sci. 2008;49:4162–8. Epub 2008 May 4116.

    Article  PubMed  Google Scholar 

  17. Ajami B, Bennett JL, Krieger C, Tetzlaff W, Rossi FM. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat Neurosci. 2007;10:1538–43. Epub 2007 Nov 1518.

    Article  PubMed  CAS  Google Scholar 

  18. Prinz M, Mildner A. Microglia in the CNS: immigrants from another world. Glia. 2011;59:177–87.

    Article  PubMed  Google Scholar 

  19. Mildner A, Schmidt H, Nitsche M, Merkler D, Hanisch UK, Mack M, et al. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat Neurosci. 2007;10:1544–53. Epub 2007 Nov 1518.

    Article  PubMed  CAS  Google Scholar 

  20. Ajami B, Bennett JL, Krieger C, McNagny KM, Rossi FM. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat Neurosci. 2011;14:1142–9. doi:1110.1038/nn.2887.

    Article  PubMed  CAS  Google Scholar 

  21. McGeer PL, McGeer EG. History of innate immunity in neurodegenerative disorders. Front Pharmacol. 2011;2:77. Epub 2011 Dec 2012.

    Article  PubMed  Google Scholar 

  22. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308:1314–8. Epub 2005 Apr 1314.

    Article  PubMed  CAS  Google Scholar 

  23. Wake H, Moorhouse AJ, Jinno S, Kohsaka S, Nabekura J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci. 2009;29:3974–80.

    Article  PubMed  CAS  Google Scholar 

  24. Griffiths M, Neal JW, Gasque P. Innate immunity and protective neuroinflammation: new emphasis on the role of neuroimmune regulatory proteins. Int Rev Neurobiol. 2007;82:29–55.

    Article  PubMed  CAS  Google Scholar 

  25. Hoarau JJ, Krejbich-Trotot P, Jaffar-Bandjee MC, Das T, Thon-Hon GV, Kumar S, et al. Activation and control of CNS innate immune responses in health and diseases: a balancing act finely tuned by neuroimmune regulators (NIReg). CNS Neurol Disord Drug Targets. 2011;10:25–43.

    Article  PubMed  CAS  Google Scholar 

  26. Zhang S, Wang XJ, Tian LP, Pan J, Lu GQ, Zhang YJ, et al. CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson’s disease. J Neuroinflammation. 2011;8:154.

    Article  PubMed  CAS  Google Scholar 

  27. Cho SH, Sun B, Zhou Y, Kauppinen TM, Halabisky B, Wes P, et al. CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease. J Biol Chem. 2011;286:32713–22. Epub 32011 Jul 32719.

    Article  PubMed  CAS  Google Scholar 

  28. Hanke ML, Kielian T. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin Sci (Lond). 2011;121:367–87.

    Article  CAS  Google Scholar 

  29. Tsuda M, Masuda T, Kitano J, Shimoyama H, Tozaki-Saitoh H, Inoue K. IFN-gamma receptor signaling mediates spinal microglia activation driving neuropathic pain. Proc Natl Acad Sci USA. 2009;106:8032–7. Epub 2009 Apr 8020.

    Article  PubMed  CAS  Google Scholar 

  30. Biber K, Neumann H, Inoue K, Boddeke HW. Neuronal ‘On’ and ‘Off’ signals control microglia. Trends Neurosci. 2007;30:596–602. Epub 2007 Oct 2024.

    Article  PubMed  CAS  Google Scholar 

  31. Milner R, Crocker SJ, Hung S, Wang X, Frausto RF, del Zoppo GJ. Fibronectin- and vitronectin-induced microglial activation and matrix metalloproteinase-9 expression is mediated by integrins alpha5beta1 and alphavbeta5. J Immunol. 2007;178:8158–67.

    PubMed  CAS  Google Scholar 

  32. Min KJ, Jou I, Joe E. Plasminogen-induced IL-1beta and TNF-alpha production in microglia is regulated by reactive oxygen species. Biochem Biophys Res Commun. 2003;312:969–74.

    Article  PubMed  CAS  Google Scholar 

  33. Banati RB, Gehrmann J, Schubert P, Kreutzberg GW. Cytotoxicity of microglia. Glia. 1993;7:111–8.

    Article  PubMed  CAS  Google Scholar 

  34. Colton CA, Wilcock DM. Assessing activation states in microglia. CNS Neurol Disord Drug Targets. 2010;9:174–91.

    PubMed  CAS  Google Scholar 

  35. Colton CA. Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol. 2009;4:399–418. Epub 2009 Aug 2005.

    Article  PubMed  Google Scholar 

  36. Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol. 2002;2:965–75.

    Article  PubMed  CAS  Google Scholar 

  37. Yoshimura T, Sonoda KH, Sugahara M, Mochizuki Y, Enaida H, Oshima Y, et al. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS One. 2009;4:e8158.

    Article  PubMed  Google Scholar 

  38. Sohn HJ, Han DH, Kim IT, Oh IK, Kim KH, Lee DY, et al. Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema. Am J Ophthalmol. 2011;152:686–94. Epub 2011 Jul 2022.

    Article  PubMed  CAS  Google Scholar 

  39. McVicar CM, Hamilton R, Colhoun LM, Gardiner TA, Brines M, Cerami A, et al. Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy. Diabetes. 2011;60:2995–3005. Epub 2011 Sep 2912.

    Article  PubMed  CAS  Google Scholar 

  40. Ibrahim AS, El-Shishtawy MM, Zhang W, Caldwell RB, Liou GI. A(A) adenosine receptor (A(A)AR) as a therapeutic target in diabetic retinopathy. Am J Pathol. 2011;178:2136–45.

    Article  PubMed  CAS  Google Scholar 

  41. Brucklacher RM, Patel KM, VanGuilder HD, Bixler GV, Barber AJ, Antonetti DA, et al. Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory response. BMC Med Genomics. 2008;1:26.

    Article  Google Scholar 

  42. Huang H, Gandhi JK, Zhong X, Wei Y, Gong J, Duh EJ, et al. TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis. Invest Ophthalmol Vis Sci. 2011;52:1336–44. Print 2011 Mar.

    Article  PubMed  CAS  Google Scholar 

  43. Wang J, Xu X, Elliott MH, Zhu M, Le YZ. Muller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage. Diabetes. 2010;59:2297–305. Epub 2010 Jun 2298.

    Article  PubMed  CAS  Google Scholar 

  44. Lin M, Chen Y, Jin J, Hu Y, Zhou KK, Zhu M, et al. Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal Muller cells. Diabetologia. 2011;54:1554–66. Epub 2011 Mar 1551.

    Article  PubMed  CAS  Google Scholar 

  45. Weller M, Esser P, Heimann K, Wiedemann P. Retinal microglia: a new cell in idiopathic proliferative vitreoretinopathy? Exp Eye Res. 1991;53:275–81.

    Article  PubMed  CAS  Google Scholar 

  46. Mitamura Y, Takeuchi S, Yamamoto S, Yamamoto T, Tsukahara I, Matsuda A, et al. Monocyte chemotactic protein-1 levels in the vitreous of patients with proliferative vitreoretinopathy. Jpn J Ophthalmol. 2002;46:218–21.

    Article  PubMed  CAS  Google Scholar 

  47. Sakamoto T, Ishibashi T. Hyalocytes: essential cells of the vitreous cavity in vitreoretinal pathophysiology? Retina. 2011;31:222–8.

    Article  PubMed  CAS  Google Scholar 

  48. Abu El-Asrar AM, Struyf S, Verbeke H, Van Damme J, Geboes K. Circulating bone-marrow-derived endothelial precursor cells contribute to neovascularization in diabetic epiretinal membranes. Acta Ophthalmol. 2011;89:222–8. doi:210.1111/j.1755-3768.2009.01700.x.

    Article  PubMed  Google Scholar 

  49. Zeng HY, Green WR, Tso MO. Microglial activation in human diabetic retinopathy. Arch Ophthalmol. 2008;126:227–32.

    Article  PubMed  Google Scholar 

  50. Devitt A, Marshall LJ. The innate immune system and the clearance of apoptotic cells. J Leukoc Biol. 2011;90:447–57. Epub 2011 May 2011.

    Article  PubMed  CAS  Google Scholar 

  51. McVicar CM, Hamilton R, Colhoun LM, Gardiner TA, Brines M, et al. Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy. Diabetes. 2011;60(11):2995–3005.

    Google Scholar 

  52. Tsai GY, Cui JZ, Syed H, Xia Z, Ozerdem U, McNeill JH, et al. Effect of N-acetylcysteine on the early expression of inflammatory markers in the retina and plasma of diabetic rats. Clin Experiment Ophthalmol. 2009;37:223–31. Epub 2009 Feb 2003.

    Article  PubMed  Google Scholar 

  53. Silva KC, Pinto CC, Biswas SK, de Faria JB, de Faria JM. Hypertension increases retinal inflammation in experimental diabetes: a possible mechanism for aggravation of diabetic retinopathy by hypertension. Curr Eye Res. 2007;32:533–41.

    Article  PubMed  CAS  Google Scholar 

  54. Zeng XX, Ng YK, Ling EA. Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis Neurosci. 2000;17:463–71.

    Article  PubMed  CAS  Google Scholar 

  55. Rungger-Brandle E, Dosso AA, Leuenberger PM. Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2000;41:1971–80.

    PubMed  CAS  Google Scholar 

  56. Gaucher D, Chiappore JA, Paques M, Simonutti M, Boitard C, Sahel JA, et al. Microglial changes occur without neural cell death in diabetic retinopathy. Vision Res. 2007;47:612–23. Epub 2006 Dec 2019.

    Article  PubMed  Google Scholar 

  57. Barber AJ, Antonetti DA, Kern TS, Reiter CE, Soans RS, Krady JK, et al. The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci. 2005;46:2210–8.

    Article  PubMed  Google Scholar 

  58. Zong H, Ward M, Stitt AW. AGEs, RAGE, and diabetic retinopathy. Curr Diab Rep. 2011;11:244–52.

    Article  PubMed  Google Scholar 

  59. Zhang W, Liu H, Rojas M, Caldwell RW, Caldwell RB. Anti-inflammatory therapy for diabetic retinopathy. Immunotherapy. 2011;3:609–28.

    Article  PubMed  CAS  Google Scholar 

  60. Tang J, Kern TS. Inflammation in diabetic retinopathy. Prog Retin Eye Res. 2011;30:343–58. Epub 2011 May 2025.

    Article  PubMed  CAS  Google Scholar 

  61. Schram MT, Chaturvedi N, Schalkwijk CG, Fuller JH, Stehouwer CD. Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes—the EURODIAB Prospective Complications Study. Diabetologia. 2005;48:370–8. Epub 2005 Feb 2004.

    Article  PubMed  CAS  Google Scholar 

  62. Nguyen TT, Alibrahim E, Islam FM, Klein R, Klein BE, Cotch MF, et al. Inflammatory, hemostatic, and other novel biomarkers for diabetic retinopathy: the multi-ethnic study of atherosclerosis. Diabetes Care. 2009;32:1704–9. Epub 2009 Jun 1723.

    Article  PubMed  CAS  Google Scholar 

  63. Klein BE, Knudtson MD, Tsai MY, Klein R. The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy. Arch Ophthalmol. 2009;127:1175–82.

    Article  PubMed  CAS  Google Scholar 

  64. van Hecke MV, Dekker JM, Nijpels G, Moll AC, Heine RJ, Bouter LM, et al. Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study. Diabetologia. 2005;48:1300–6. Epub 2005 May 1326.

    Article  PubMed  CAS  Google Scholar 

  65. Spijkerman AM, Gall MA, Tarnow L, Twisk JW, Lauritzen E, Lund-Andersen H, et al. Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in type 2 diabetes. Diabet Med. 2007;24:969–76. Epub 2007 Jun 2025.

    Article  PubMed  CAS  Google Scholar 

  66. Izuora KE, Chase HP, Jackson WE, Coll JR, Osberg IM, Gottlieb PA, et al. Inflammatory markers and diabetic retinopathy in type 1 diabetes. Diabetes Care. 2005;28:714–5.

    Article  PubMed  CAS  Google Scholar 

  67. Lim LS, Tai ES, Mitchell P, Wang JJ, Tay WT, Lamoureux E, et al. C-reactive protein, body mass index, and diabetic retinopathy. Invest Ophthalmol Vis Sci. 2010;51:4458–63.

    Article  PubMed  Google Scholar 

  68. Ibrahim AS, El-Remessy AB, Matragoon S, Zhang W, Patel Y, Khan S, et al. Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes. Diabetes. 2011;60:1122–33. Epub 2011 Feb 1111.

    Article  PubMed  CAS  Google Scholar 

  69. Koistinaho M, Koistinaho J. Role of p38 and p44/42 mitogen-activated protein kinases in microglia. Glia. 2002;40:175–83.

    Article  PubMed  Google Scholar 

  70. Ibrahim AS, El-Shishtawy MM, Pena Jr A, Liou GI. Genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation. Mol Vis. 2010;16:2033–42.

    PubMed  CAS  Google Scholar 

  71. Schalkwijk CG. Comment on “AGEs mediated expression and secretion of TNF alpha in rat retinal microglia” by Dr Wang et al. Exp Eye Res. 2007;85:572–3. author reply 574. Epub 2007 Jul 2015.

    Article  PubMed  CAS  Google Scholar 

  72. McColl A, Bournazos S, Franz S, Perretti M, Morgan BP, Haslett C, et al. Glucocorticoids induce protein S-dependent phagocytosis of apoptotic neutrophils by human macrophages. J Immunol. 2009;183:2167–75. Epub 2009 Jul 2113.

    Article  PubMed  CAS  Google Scholar 

  73. Heasman SJ, Giles KM, Ward C, Rossi AG, Haslett C, Dransfield I. Glucocorticoid-mediated regulation of granulocyte apoptosis and macrophage phagocytosis of apoptotic cells: implications for the resolution of inflammation. J Endocrinol. 2003;178:29–36.

    Article  PubMed  CAS  Google Scholar 

  74. Walsh GM, Sexton DW, Blaylock MG. Corticosteroids, eosinophils and bronchial epithelial cells: new insights into the resolution of inflammation in asthma. J Endocrinol. 2003;178:37–43.

    Article  PubMed  CAS  Google Scholar 

  75. Soehnlein O, Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol. 2010;10:427–39.

    Article  PubMed  CAS  Google Scholar 

  76. Saederup N, Cardona AE, Croft K, Mizutani M, Cotleur AC, Tsou CL, et al. Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice. PLoS One. 2010;5:e13693.

    Article  PubMed  Google Scholar 

  77. Schroder S, Palinski W, Schmid-Schonbein GW. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol. 1991;139:81–100.

    PubMed  CAS  Google Scholar 

  78. Adamis AP. Is diabetic retinopathy an inflammatory disease? Br J Ophthalmol. 2002;86:363–5.

    Article  PubMed  CAS  Google Scholar 

  79. Patel N. Targeting leukostasis for the treatment of early diabetic retinopathy. Cardiovasc Hematol Disord Drug Targets. 2009;9:222–9.

    Article  PubMed  CAS  Google Scholar 

  80. Kaji Y, Usui T, Ishida S, Yamashiro K, Moore TC, Moore J, et al. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products. Invest Ophthalmol Vis Sci. 2007;48:858–65.

    Article  PubMed  Google Scholar 

  81. Joussen AM, Poulaki V, Qin W, Kirchhof B, Mitsiades N, Wiegand SJ, et al. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am J Pathol. 2002;160:501–9.

    Article  PubMed  CAS  Google Scholar 

  82. Miyamoto K, Khosrof S, Bursell SE, Rohan R, Murata T, Clermont AC, et al. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci USA. 1999;96:10836–41.

    Article  PubMed  CAS  Google Scholar 

  83. Barouch FC, Miyamoto K, Allport JR, Fujita K, Bursell SE, Aiello LP, et al. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Invest Ophthalmol Vis Sci. 2000;41:1153–8.

    PubMed  CAS  Google Scholar 

  84. Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004;18:1450–2. Epub 2004 Jul 1451.

    PubMed  CAS  Google Scholar 

  85. He P. Leucocyte/endothelium interactions and microvessel permeability: coupled or uncoupled? Cardiovasc Res. 2010;87:281–90. Epub 2010 May 2013.

    Article  PubMed  CAS  Google Scholar 

  86. Joussen AM, Poulaki V, Mitsiades N, Cai WY, Suzuma I, Pak J, et al. Suppression of Fas-FasL-induced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocin-induced diabetes. FASEB J. 2003;17:76–8. Epub 2002 Nov 2015.

    PubMed  CAS  Google Scholar 

  87. Semple BD, Kossmann T, Morganti-Kossmann MC. Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. J Cereb Blood Flow Metab. 2010;30:459–73. Epub 2009 Nov 2011.

    Article  PubMed  CAS  Google Scholar 

  88. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest. 1989;84:1045–9.

    Article  PubMed  CAS  Google Scholar 

  89. Bell MD, Taub DD, Perry VH. Overriding the brain’s intrinsic resistance to leukocyte recruitment with intraparenchymal injections of recombinant chemokines. Neuroscience. 1996;74:283–92.

    Article  PubMed  CAS  Google Scholar 

  90. Lee TH, Avraham H, Lee SH, Avraham S. Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells. J Biol Chem. 2002;277:10445–51. Epub 12002 Jan 10449.

    Article  PubMed  CAS  Google Scholar 

  91. Prinz M, Priller J. Tickets to the brain: role of CCR2 and CX3CR1 in myeloid cell entry in the CNS. J Neuroimmunol. 2010;224:80–4. Epub 2010 May 2031.

    Article  PubMed  CAS  Google Scholar 

  92. Dzenko KA, Song L, Ge S, Kuziel WA, Pachter JS. CCR2 expression by brain microvascular endothelial cells is critical for macrophage transendothelial migration in response to CCL2. Microvasc Res. 2005;70:53–64. Epub 2005 May 2031.

    Article  PubMed  CAS  Google Scholar 

  93. Huang D, Wujek J, Kidd G, He TT, Cardona A, Sasse ME, et al. Chronic expression of monocyte chemoattractant protein-1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice. FASEB J. 2005;19:761–72.

    Article  PubMed  CAS  Google Scholar 

  94. Joly S, Francke M, Ulbricht E, Beck S, Seeliger M, Hirrlinger P, et al. Cooperative phagocytes: resident microglia and bone marrow immigrants remove dead photoreceptors in retinal lesions. Am J Pathol. 2009;174:2310–23. Epub 2009 May 2312.

    Article  PubMed  CAS  Google Scholar 

  95. Rutar M, Natoli R, Valter K, Provis JM. Early focal expression of the chemokine Ccl2 by Muller cells during exposure to damage-inducing bright continuous light. Invest Ophthalmol Vis Sci. 2011;52:2379–88. Print 2011 Apr.

    Article  PubMed  CAS  Google Scholar 

  96. Stamatovic SM, Shakui P, Keep RF, Moore BB, Kunkel SL, Van Rooijen N, et al. Monocyte chemoattractant protein-1 regulation of blood–brain barrier permeability. J Cereb Blood Flow Metab. 2005;25:593–606.

    Article  PubMed  CAS  Google Scholar 

  97. Woo SJ, Ahn SJ, Ahn J, Park KH, Lee K. Elevated systemic neutrophil count in diabetic retinopathy and diabetes: a hospital-based cross-sectional study of 30,793 Korean subjects. Invest Ophthalmol Vis Sci. 2011;52:7697–703. Print 2011 Sep.

    Article  PubMed  Google Scholar 

  98. Song H, Wang L, Hui Y. Expression of CD18 on the neutrophils of patients with diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2007;245:24–31. Epub 2006 Jul 2018.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology and Visual Science, Kellogg Eye Center, University of Michigan, 1000 Wall Street, Ann Arbor, MI, 48105, USA

    Steven F. Abcouwer

Authors
  1. Steven F. Abcouwer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven F. Abcouwer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abcouwer, S.F. Neural inflammation and the microglial response in diabetic retinopathy. j ocul biol dis inform 4, 25–33 (2011). https://doi.org/10.1007/s12177-012-9086-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12177-012-9086-x

Keywords

Search

Navigation